Literature DB >> 28105357

Immunoglobulin G4-mediated sclerosing cholangitis as a risk factor for cholangiocarcinoma: A case report.

Karin E Koopman1, Elisabeth Bloemena2, Geert Kazemier3, Michael Klemt-Kropp1.   

Abstract

Immunoglobulin (Ig)G4-mediated disease is a systemic autoimmune disease, which occasionally presents solely as sclerosing cholangitis (SC). IgG4-mediated SC is challenging to diagnose, as it may mimic cholangiocarcinoma radiologically, and carcinoma cells may produce IgG4. The diagnosis of IgG4-mediated disease is based on histological consensus criteria and response to corticosteroids. In addition to the radiological and histological overlap between IgG4-mediated SC and cholangiocarcinoma, IgG4-mediated SC may be considered as a risk factor for the development of cholangiocarcinoma. We herein present the case of a patient in whom cholangiocarcinoma developed in two lesions previously characterized as IgG4-mediated SC, including a suggested mechanism underlying the contribution of IgG4-mediated SC to the development of cholangiocarcinoma.

Entities:  

Keywords:  cholangiocarcinoma; immunoglobulin G4-mediated disease; immunoglobulin G4-mediated sclerosing cholangitis

Year:  2016        PMID： 28105357      PMCID： PMC5228479          DOI： 10.3892/mco.2016.1040

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN： 2049-9450


  17 in total

Review 1.  Consensus statement on the pathology of IgG4-related disease.

Authors:  Vikram Deshpande; Yoh Zen; John Kc Chan; Eunhee E Yi; Yasuharu Sato; Tadashi Yoshino; Günter Klöppel; J Godfrey Heathcote; Arezou Khosroshahi; Judith A Ferry; Rob C Aalberse; Donald B Bloch; William R Brugge; Adrian C Bateman; Mollie N Carruthers; Suresh T Chari; Wah Cheuk; Lynn D Cornell; Carlos Fernandez-Del Castillo; David G Forcione; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Gregory Y Lauwers; Yasufumi Masaki; Yasuni Nakanuma; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant V Sahani; Thomas C Smyrk; James R Stone; Masayuki Takahira; George J Webster; Motohisa Yamamoto; Giuseppe Zamboni; Hisanori Umehara; John H Stone
Journal:  Mod Pathol       Date:  2012-05-18       Impact factor: 7.842

Review 2.  IgG4-related disease: a systemic condition with characteristic microscopic features.

Authors:  Sönke Detlefsen
Journal:  Histol Histopathol       Date:  2012-12-24       Impact factor: 2.303

3.  Involvement of inducible costimulator- and interleukin 10-positive regulatory T cells in the development of IgG4-related autoimmune pancreatitis.

Authors:  Takeo Kusuda; Kazushige Uchida; Hideaki Miyoshi; Masanori Koyabu; Sohei Satoi; Makoto Takaoka; Nobuaki Shikata; Yoshiko Uemura; Kazuichi Okazaki
Journal:  Pancreas       Date:  2011-10       Impact factor: 3.327

Review 4.  Primary sclerosing cholangitis: overview and update.

Authors:  Flavia Mendes; Keith D Lindor
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-12       Impact factor: 46.802

5.  Early bile duct cancer in a background of sclerosing cholangitis and autoimmune pancreatitis.

Authors:  Hyoung-Chul Oh; Jae Gyu Kim; Jeong Wook Kim; Kwang Sun Lee; Mi Kyung Kim; Kyong Choun Chi; Yong Seok Kim; Ki Hyun Kim
Journal:  Intern Med       Date:  2008-12-01       Impact factor: 1.271

6.  Pancreatic cancer associated with autoimmune pancreatitis in remission.

Authors:  Toshiro Fukui; Toshiyuki Mitsuyama; Makoto Takaoka; Kazushige Uchida; Mitsunobu Matsushita; Kazuichi Okazaki
Journal:  Intern Med       Date:  2008-02-01       Impact factor: 1.271

7.  IgG4-related sclerosing lymphoplasmacytic pancreatitis and cholangitis mimicking carcinoma of pancreas and Klatskin tumour.

Authors:  Moon-Tong Cheung; Irene Lai-Oi Lo
Journal:  ANZ J Surg       Date:  2008-04       Impact factor: 1.872

8.  Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis.

Authors:  Raffaele Pezzilli; Silvia Vecchiarelli; Maria Cristina Di Marco; Carla Serra; Donatella Santini; Lucia Calculli; Dario Fabbri; Betzabè Rojas Mena; Andrea Imbrogno
Journal:  Case Rep Gastroenterol       Date:  2011-07-09

9.  Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort.

Authors:  Matthew T Huggett; E L Culver; George J M Webster; E Barnes; M Kumar; J M Hurst; M Rodriguez-Justo; M H Chapman; G J Johnson; S P Pereira; R W Chapman
Journal:  Am J Gastroenterol       Date:  2014-08-26       Impact factor: 10.864

10.  Immunoglobulin G4-related sclerosing cholangitis mimicking hilar cholangiocarcinoma diagnosed with following bile duct resection: report of a case.

Authors:  Atsushi Miki; Yasunaru Sakuma; Hideyuki Ohzawa; Yukihiro Sanada; Hideki Sasanuma; Alan T Lefor; Naohiro Sata; Yoshikazu Yasuda
Journal:  Int Surg       Date:  2015-03
View more
  2 in total

1.  IgG4-related sclerosing cholangitis mimicking hilar cholangiocarcinoma (Klatskin tumor): a case report of a challenging disease and review of the literature.

Authors:  Anke Mittelstaedt; Peter N Meier; Eva Dankoweit-Timpe; Beate Christ; Joachim Jaehne
Journal:  Innov Surg Sci       Date:  2018-05-25

2.  Klatskin tumor diagnosed concurrently with IgG4 related sclerosing cholangitis: A case report.

Authors:  Ha Won Hwang; Jin-Seok Park; Seok Jeong; Don Haeng Lee; Suk Jin Choi
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.